Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 569 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Corvus Pharmaceuticals, Inc.
Market Cap
$864.50M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$878.06M
Net Profit Margin
84.23%
TTM Avg
-685.46%
3Y Avg
-487.63%
5Y Avg
-594.40%
Market Cap
$845.05M
Net Profit Margin
-560.85%
TTM Avg
-63.69%
3Y Avg
-31.84%
5Y Avg
-21.23%
Market Cap
$844.91M
Net Profit Margin
-61.32%
TTM Avg
-78.55%
3Y Avg
-9174.62%
5Y Avg
-9174.62%
Market Cap
$901.05M
Net Profit Margin
9.36%
TTM Avg
-0.92%
3Y Avg
-15.83%
5Y Avg
-8.95%
Market Cap
$826.99M
Net Profit Margin
-5933.45%
TTM Avg
-505.88%
3Y Avg
-252.94%
5Y Avg
-252.94%
Market Cap
$911.51M
Net Profit Margin
6.60%
TTM Avg
6.45%
3Y Avg
5.72%
5Y Avg
5.15%
Market Cap
$811.26M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corvus Pharmaceuticals, Inc. (CRVS) | $864.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| Arbutus Biopharma Corp (ABUS)vs › | $878.06M | 84.23% | -685.46% | -487.63% | -594.40% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $845.05M | -560.85% | -63.69% | -31.84% | -21.23% |
| Beta Bionics, Inc. (BBNX)vs › | $844.91M | -61.32% | -78.55% | -9174.62% | -9174.62% |
| Bioventus Inc. (BVS)vs › | $901.05M | 9.36% | -0.92% | -15.83% | -8.95% |
| Alumis Inc. (ALMS)vs › | $826.99M | -5933.45% | -505.88% | -252.94% | -252.94% |
| Apnimed, Inc. (APMD)vs › | $817.57M | N/A | N/A | N/A | N/A |
| HealthStream, Inc. (HSTM)vs › | $911.51M | 6.60% | 6.45% | 5.72% | 5.15% |
| Jade Biosciences, Inc. (JBIO)vs › | $811.26M | 0.00% | 0.00% | 0.00% | 0.00% |
| InMode Ltd. (INMD)vs › | $809.46M | 20.69% | 35.62% | 36.75% | 38.26% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
